Platelet-rich plasma (PRP) is a biological therapy that uses the patient's own blood to obtain products with a higher platelet concentration than in blood. It provides a transient fibrin scaffold as a controlled drug delivery system of growth factors suitable for regenerative medicine.
This report contains market size and forecasts of Plasma Therapy in Southeast Asia, including the following market information:
Southeast Asia Plasma Therapy Market Revenue, 2015-2020, 2021-2026, ($ millions)
Top Five Competitors in Southeast Asia Plasma Therapy Market 2019 (%)
The global Plasma Therapy market was valued at 225 million in 2019 and is projected to reach US$ 324.3 million by 2026, at a CAGR of 9.6% during the forecast period. While the Plasma Therapy market size in Southeast Asia was US$ XX million in 2019, and it is expected to reach US$ XX million by the end of 2026, with a CAGR of XX% during 2020-2026.
COVID-19 pandemic has big impact on Plasma Therapy businesses, with lots of challenges and uncertainty faced by many players of Plasma Therapy in Southeast Asia. This report also analyses and evaluates the COVID-19 impact on Plasma Therapy market size in 2020 and the next few years in Southeast Asia
Total Market by Segment:
Southeast Asia Plasma Therapy Market, By Type, 2015-2020, 2021-2026 ($ millions)
Southeast Asia Plasma Therapy Market Segment Percentages, By Type, 2019 (%)
- Pure PRP
- Leucocyte-rich PRP
- Leukocyte-rich Fibrin (L-PRF)
- In 2018, Pure PRP accounted for a major share of 66% the global Plasma Therapy market, this product segment is poised to reach 256.82 million US$ by 2025 from 130.82 million US$ in 2018.
Southeast Asia Plasma Therapy Market, By Application, 2015-2020, 2021-2026 ($ millions)
Southeast Asia Plasma Therapy Market Segment Percentages, By Application, 2019 (%)
- Orthopedic
- Darmatology
- Cardiac Muscle Injury
- Dental
- Nerve Injury
- Plasma Therapy is application for Orthopedic, Dermatology, Cardiac Muscle Injury, Dental, Nerve Injury and Others. The most of Plasma Therapy is used for Orthopedic, and the market share of that is about 70.53 % in 2018.Followed by Dramatology,which occupied 11.19% in 2018.
Competitor Analysis
The report also provides analysis of leading market participants including:
Total Plasma Therapy Market Competitors Revenues in Southeast Asia, by Players 2015-2020 (Estimated), ($ millions)
Total Plasma Therapy Market Competitors Revenues Share in Southeast Asia, by Players 2019 (%)
Further, the report presents profiles of competitors in the market, including the following:
- Terumo
- Arthrex
- Zimmer Biomet
- DePuy Synthes
- EmCyte
- Regen Lab
- ISTO Biologics
- Cesca Therapeutics
- Weigao
- REV-MED
Plasma Therapy Market in Southeast Asia - Industry Outlook and Forecast 2020-2026
Table of Contents
1 Introduction to Research & Analysis Reports
1.1 Plasma Therapy Market Definition
1.2 Market Segments
1.2.1 Segment by Type
1.2.2 Segment by Application
1.3 COVID-19 Impact: Southeast Asia Plasma Therapy Market Overview
1.4 Features & Benefits of This Report
1.5 Methodology & Sources of Information
1.5.1 Research Methodology
1.5.2 Research Process
1.5.3 Base Year
1.5.4 Report Assumptions & Caveats
2 Southeast Asia Plasma Therapy Overall Market Size
2.1 Southeast Asia Plasma Therapy Market Size: 2020 VS 2026
2.2 Southeast Asia Plasma Therapy Revenue, Prospects & Forecasts: 2015-2026
3 Company Landscape
3.1 Top Plasma Therapy Players in Southeast Asia (including Foreign and Local Companies)
3.2 Top Southeast Asia Plasma Therapy Companies Ranked by Revenue
3.3 Southeast Asia Plasma Therapy Revenue by Companies (including Foreign and Local Companies)
3.4 Top 3 and Top 5 Plasma Therapy Companies in Southeast Asia, by Revenue in 2019
3.5 Southeast Asia Manufacturers Plasma Therapy Product Type
3.6 Tier 1, Tier 2 and Tier 3 Plasma Therapy Players in Southeast Asia
3.6.1 List of Southeast Asia Tier 1 Plasma Therapy Companies
3.6.2 List of Southeast Asia Tier 2 and Tier 3 Plasma Therapy Companies
4 Sights by Product
4.1 Overview
4.1.1 By Type - Southeast Asia Plasma Therapy Market Size Markets, 2020 & 2026
4.1.2 Pure PRP
4.1.3 Leucocyte-rich PRP
4.1.4 Leukocyte-rich Fibrin (L-PRF)
4.2 By Type - Southeast Asia Plasma Therapy Revenue & Forecasts
4.2.1 By Type - Southeast Asia Plasma Therapy Revenue, 2015-2020
4.2.2 By Type - Southeast Asia Plasma Therapy Revenue, 2021-2026
4.2.3 By Type - Southeast Asia Plasma Therapy Revenue Market Share, 2015-2026
5 Sights by Application
5.1 Overview
5.1.1 By Application - Southeast Asia Plasma Therapy Market Size, 2020 & 2026
5.1.2 Orthopedic
5.1.3 Darmatology
5.1.4 Cardiac Muscle Injury
5.1.5 Dental
5.1.6 Nerve Injury
5.2 By Application - Southeast Asia Plasma Therapy Revenue & Forecasts
5.2.1 By Application - Southeast Asia Plasma Therapy Revenue, 2015-2020
5.2.2 By Application - Southeast Asia Plasma Therapy Revenue, 2021-2026
5.2.3 By Application - Southeast Asia Plasma Therapy Revenue Market Share, 2015-2026
6 Players Profiles
6.1 Terumo
6.1.1 Terumo Corporate Summary
6.1.2 Terumo Business Overview
6.1.3 Terumo Plasma Therapy Major Product Offerings
6.1.4 Terumo Revenue in Southeast Asia (2015-2020)
6.1.5 Terumo Key News
6.2 Arthrex
6.2.1 Arthrex Corporate Summary
6.2.2 Arthrex Business Overview
6.2.3 Arthrex Plasma Therapy Major Product Offerings
6.2.4 Arthrex Revenue in Southeast Asia (2015-2020)
6.2.5 Arthrex Key News
6.3 Zimmer Biomet
6.3.1 Zimmer Biomet Corporate Summary
6.3.2 Zimmer Biomet Business Overview
6.3.3 Zimmer Biomet Plasma Therapy Major Product Offerings
6.3.4 Zimmer Biomet Revenue in Southeast Asia (2015-2020)
6.3.5 Zimmer Biomet Key News
6.4 DePuy Synthes
6.4.1 DePuy Synthes Corporate Summary
6.4.2 DePuy Synthes Business Overview
6.4.3 DePuy Synthes Plasma Therapy Major Product Offerings
6.4.4 DePuy Synthes Revenue in Southeast Asia (2015-2020)
6.4.5 DePuy Synthes Key News
6.5 EmCyte
6.5.1 EmCyte Corporate Summary
6.5.2 EmCyte Business Overview
6.5.3 EmCyte Plasma Therapy Major Product Offerings
6.5.4 EmCyte Revenue in Southeast Asia (2015-2020)
6.5.5 EmCyte Key News
6.6 Regen Lab
6.6.1 Regen Lab Corporate Summary
6.6.2 Regen Lab Business Overview
6.6.3 Regen Lab Plasma Therapy Major Product Offerings
6.6.4 Regen Lab Revenue in Southeast Asia (2015-2020)
6.6.5 Regen Lab Key News
6.7 ISTO Biologics
6.6.1 ISTO Biologics Corporate Summary
6.6.2 ISTO Biologics Business Overview
6.6.3 ISTO Biologics Plasma Therapy Major Product Offerings
6.4.4 ISTO Biologics Revenue in Southeast Asia (2015-2020)
6.7.5 ISTO Biologics Key News
6.8 Cesca Therapeutics
6.8.1 Cesca Therapeutics Corporate Summary
6.8.2 Cesca Therapeutics Business Overview
6.8.3 Cesca Therapeutics Plasma Therapy Major Product Offerings
6.8.4 Cesca Therapeutics Revenue in Southeast Asia (2015-2020)
6.8.5 Cesca Therapeutics Key News
6.9 Weigao
6.9.1 Weigao Corporate Summary
6.9.2 Weigao Business Overview
6.9.3 Weigao Plasma Therapy Major Product Offerings
6.9.4 Weigao Revenue in Southeast Asia (2015-2020)
6.9.5 Weigao Key News
6.10 REV-MED
6.10.1 REV-MED Corporate Summary
6.10.2 REV-MED Business Overview
6.10.3 REV-MED Plasma Therapy Major Product Offerings
6.10.4 REV-MED Revenue in Southeast Asia (2015-2020)
6.10.5 REV-MED Key News
6.11 Nuo Therapeutics
6.11.1 Nuo Therapeutics Corporate Summary
6.11.2 Nuo Therapeutics Plasma Therapy Business Overview
6.11.3 Nuo Therapeutics Plasma Therapy Major Product Offerings
6.11.4 Nuo Therapeutics Revenue in Southeast Asia (2015-2020)
6.11.5 Nuo Therapeutics Key News
7 Key Market Trends & Influences 2021-2026
7.1 PESTLE Analysis for Southeast Asia Plasma Therapy Market
7.2 Market Opportunities & Trends
7.3 Market Drivers
7.4 Market Restraints
8 Conclusion
9 Appendix
9.1 Note
9.2 Examples of Clients
9.3 Disclaimer
List of Tables
Table 1. Key Players of Plasma Therapy in Southeast Asia
Table 2. Top Players in Southeast Asia, Ranking by Revenue (2019)
Table 3. Southeast Asia Plasma Therapy Revenue by Companies, (US$, Mn), 2015-2020
Table 4. Southeast Asia Plasma Therapy Revenue Share by Companies, 2015-2020
Table 5. Southeast Asia Plasma Therapy Sales by Companies, (K Units), 2015-2020
Table 6. Southeast Asia Plasma Therapy Sales Share by Companies, 2015-2020
Table 7. Key Manufacturers Plasma Therapy Price (2015-2020) (US$/Unit)
Table 8. Southeast Asia Manufacturers Plasma Therapy Product Type
Table 9. List of Southeast Asia Tier 1 Plasma Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 10. List of Southeast Asia Tier 2 and Tier 3 Plasma Therapy Companies, Revenue (US$, Mn) in 2019 and Market Share
Table 11. By Type - Plasma Therapy Revenue in Southeast Asia (US$, Mn), 2015-2020
Table 12. By Type - Plasma Therapy Revenue in Southeast Asia (US$, Mn), 2021-2026
Table 13. By Type - Plasma Therapy Sales in Southeast Asia (K Units), 2015-2020
Table 14. By Type - Plasma Therapy Sales in Southeast Asia (K Units), 2021-2026
Table 15. By Application - Plasma Therapy Revenue in Southeast Asia, (US$, Mn), 2015-2020
Table 16. By Application - Plasma Therapy Revenue in Southeast Asia, (US$, Mn), 2021-2026
Table 17. By Application - Plasma Therapy Sales in Southeast Asia, (K Units), 2015-2020
Table 18. By Application - Plasma Therapy Sales in Southeast Asia, (K Units), 2021-2026
Table 19. Terumo Corporate Summary
Table 20. Terumo Plasma Therapy Product Offerings
Table 21. Terumo Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 22. Arthrex Corporate Summary
Table 23. Arthrex Plasma Therapy Product Offerings
Table 24. Arthrex Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 25. Zimmer Biomet Corporate Summary
Table 26. Zimmer Biomet Plasma Therapy Product Offerings
Table 27. Zimmer Biomet Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 28. DePuy Synthes Corporate Summary
Table 29. DePuy Synthes Plasma Therapy Product Offerings
Table 30. DePuy Synthes Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 31. EmCyte Corporate Summary
Table 32. EmCyte Plasma Therapy Product Offerings
Table 33. EmCyte Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 34. Regen Lab Corporate Summary
Table 35. Regen Lab Plasma Therapy Product Offerings
Table 36. Regen Lab Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 37. ISTO Biologics Corporate Summary
Table 38. ISTO Biologics Plasma Therapy Product Offerings
Table 39. ISTO Biologics Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 40. Cesca Therapeutics Corporate Summary
Table 41. Cesca Therapeutics Plasma Therapy Product Offerings
Table 42. Cesca Therapeutics Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 43. Weigao Corporate Summary
Table 44. Weigao Plasma Therapy Product Offerings
Table 45. Weigao Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 46. REV-MED Corporate Summary
Table 47. REV-MED Plasma Therapy Product Offerings
Table 48. REV-MED Plasma Therapy Revenue (US$, Mn), (2015-2020)
Table 49. Nuo Therapeutics Corporate Summary
Table 50. Nuo Therapeutics Plasma Therapy Product Offerings
Table 51. Nuo Therapeutics Plasma Therapy Revenue (US$, Mn), (2015-2020)
List of Figures
Figure 1. Plasma Therapy Segment by Type
Figure 2. Plasma Therapy Segment by Application
Figure 3. Southeast Asia Plasma Therapy Market Overview: 2020
Figure 4. Key Caveats
Figure 5. Plasma Therapy Market Size in Southeast Asia, (US$, Mn): 2020 VS 2026
Figure 6. Southeast Asia Plasma Therapy Revenue, 2015-2026 (US$, Mn)
Figure 7. The Top 3 and 5 Players Market Share by Plasma Therapy Revenue in 2019
Figure 8. By Type - Southeast Asia Plasma Therapy Incremental Growth, (US$, Mn), 2015-2026
Figure 9. By Type - Southeast Asia Plasma Therapy Market Share, 2015-2026
Figure 10. By Application - Plasma Therapy Revenue in Southeast Asia (US$, Mn), 2020 & 2026
Figure 11. By Application - Southeast Asia Plasma Therapy Market Share, 2015-2026
Figure 12. PEST Analysis for Southeast Asia Plasma Therapy Market in 2020
Figure 13. Plasma Therapy Market Opportunities & Trends in Southeast Asia
Figure 14. Plasma Therapy Market Drivers in Southeast Asia
Global Thyroid Gland Disorders Treatment Market Research Report 2024
Published: 10-Jan-2024 Price: US 2900 Onwards Pages: 80
Thyroid Gland Disorder Treatment is a kind of treatment method, which aims to The thyroid disorder patients, such as hypothyroidism patients and hyperthyroidism patients. When The thyroid gland does not produce sufficient hypothyroidism or too much hyperthyroidism, The body metabolism and functioning will be disrupted.
The global Thyroid Gland Disorders Treatment market was valued at US$ 2950 million in 2023 and is anticipated to reach US$ 3871.9 million by 2030, witnessing a CAGR o......
Global Brachytherapy Afterloaders, Brachytherapy Seeds Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 98
According to our LPI (LP Information) latest study, the global Brachytherapy Afterloaders, Brachytherapy Seeds market size was valued at US$ 150.8 million in 2023. With growing demand in downstream market, the Brachytherapy Afterloaders, Brachytherapy Seeds is forecast to a readjusted size of US$ 168.1 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Brachytherapy Afterloaders, Brachytherapy Seeds market. Brachyth......
Global Peptide Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Peptide Therapeutics market size was valued at US$ 33800 million in 2023. With growing demand in downstream market, the Peptide Therapeutics is forecast to a readjusted size of US$ 63130 million by 2030 with a CAGR of 9.3% during review period.
The research report highlights the growth potential of the global Peptide Therapeutics market. Peptide Therapeutics are expected to show stable growth in the future market. However, pr......
Global Microbiome Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 155
According to our LPI (LP Information) latest study, the global Microbiome Therapeutics market size was valued at US$ 89 million in 2023. With growing demand in downstream market, the Microbiome Therapeutics is forecast to a readjusted size of US$ 916.3 million by 2030 with a CAGR of 39.5% during review period.
The research report highlights the growth potential of the global Microbiome Therapeutics market. Microbiome Therapeutics are expected to show stable growth in the future market. H......
Global Anti-inflammatory Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 109
According to our LPI (LP Information) latest study, the global Anti-inflammatory Therapeutics market size was valued at US$ 108140 million in 2023. With growing demand in downstream market, the Anti-inflammatory Therapeutics is forecast to a readjusted size of US$ 166150 million by 2030 with a CAGR of 6.3% during review period.
The research report highlights the growth potential of the global Anti-inflammatory Therapeutics market. Anti-inflammatory Therapeutics are expected to show stabl......
Global Enzyme Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 113
According to our LPI (LP Information) latest study, the global Enzyme Replacement Therapy market size was valued at US$ 11570 million in 2023. With growing demand in downstream market, the Enzyme Replacement Therapy is forecast to a readjusted size of US$ 29900 million by 2030 with a CAGR of 14.5% during review period.
The research report highlights the growth potential of the global Enzyme Replacement Therapy market. Enzyme Replacement Therapy are expected to show stable growth in the f......
Global Infantile Spasms Therapeutics Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 84
According to our LPI (LP Information) latest study, the global Infantile Spasms Therapeutics market size was valued at US$ 138.9 million in 2023. With growing demand in downstream market, the Infantile Spasms Therapeutics is forecast to a readjusted size of US$ 179.6 million by 2030 with a CAGR of 3.7% during review period.
The research report highlights the growth potential of the global Infantile Spasms Therapeutics market. Infantile Spasms Therapeutics are expected to show stable grow......
Global Hormone Replacement Therapy Market Growth 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 128
According to our LPI (LP Information) latest study, the global Hormone Replacement Therapy market size was valued at US$ 16090 million in 2023. With growing demand in downstream market, the Hormone Replacement Therapy is forecast to a readjusted size of US$ 17930 million by 2030 with a CAGR of 1.6% during review period.
The research report highlights the growth potential of the global Hormone Replacement Therapy market. Hormone Replacement Therapy are expected to show stable growth in th......
Global Plasma Therapy Market Growth (Status and Outlook) 2024-2030
Published: 04-Jan-2024 Price: US 3660 Onwards Pages: 107
According to our LPI (LP Information) latest study, the global Plasma Therapy market size was valued at US$ 265.3 million in 2023. With growing demand in downstream market, the Plasma Therapy is forecast to a readjusted size of US$ 529.4 million by 2030 with a CAGR of 10.4% during review period.
The research report highlights the growth potential of the global Plasma Therapy market. Plasma Therapy are expected to show stable growth in the future market. However, product differentiation, ......
SERVICES
Value for Money
We believe in "optimum utilization of available budget and resources". While servicing our clients' (your) market research requirements, we keep the same approach in focus to help you get the best value for your $$s.
Ever Growing Inventory
Ranging from the smallest feasible / required data (datasheets, data facts, SWOT analysis, company profiles, etc) to full research reports that help you make decisions, our inventory is updated almost on a daily basis with the latest industry reports from domain experts that track more than 5000 niche sectors.
One Stop Solution
Need a custom research report on medical devices market? Require all available business intelligence on 3D printing industry? Exploring F&B sector of a particular country/region? RnRMarketResearch.com is your one-stop-solution to all market intelligence needs. We not only offer custom research and consulting services, we also "bundle" reports to meet your needs and help you fetch the data analysis you require for your business.
Dedicated Client Engagement
Not limited to only "finding" relevant reports for you, our client engagement team dedicates its efforts to understand your "business need" and accordingly maps available research data to help you move forward. Call "your" client engagement executive any time of your day and get your questions answered in order to make the correct business decision.
Saving Time and Efforts
Simply share your research requirement details with us and let us do all the hard work to find required intelligence for you. When you add up our "one stop solution" and "dedicated client engagement" services mentioned above, you obviously know the time and effort saving you do by working with us.
Payment Flexibility
Working with Fortune 500 organizations, we understand the importance of being flexible for payments. Share your payment terms with us and we will surely match up to them to ensure you get access to required business intelligence data without having to wait for the payment to be done.
Post-Purchase Research Support
Have questions after reading a report / datasheet bought through us? Not sure about the methodology used for data available in the research? Talk to us / Share your questions with us and if required, we will connect you with the analyst(s)/author(s) of the report(s) and ensure you get satisfactory answers for the same. Need more data / analysis / report(s) on the topic of your research/project? The RnRMarketResearch.com team is here for you 24X7 to support you with your post-purchase requirements.
Subscription Offers & Packages (Get in touch with us for more details -
[email protected] / +1 888 391 5441 )
- Ad Hoc
-
- Pay - as - you - go / Bucket Subscriptions
- Fixed Cost for #of reports
- Customize / Personalize as per your needs
